期刊文献+

三阴性乳腺癌的治疗 被引量:7

The therapy for triple negative breast cancer
原文传递
导出
摘要 三阴性乳腺癌(TNBC)是具有特殊侵袭性生物学行为及临床病理特征的一个乳腺癌亚型,其治疗一直是乳腺癌中的难点和热点问题。目前,手术和辅助放疗仍是早期TNBC局部治疗的主要方式,传统化疗、靶向治疗研究在TNBC的全身治疗中取得了一定的进展,同时,近几年新药物也不断涌现出来。 Triple negative breast cancer (TNBC) is a special subgroup of breast cancer with more aggressive biological behavior and clinicopathological characteristics, and the therapy of TNBC has always been the research difficulty and hot spot. Currently, surgery and adjuvant radiotherapy are still the main method in local treatment, amd the research of traditional chemotherapy and targeted therapy have been made some pro- gress. Meanwhile, new drugs continuously appear in recent years.
出处 《国际肿瘤学杂志》 CAS 2014年第6期443-446,共4页 Journal of International Oncology
关键词 乳腺肿瘤 外科手术 放射疗法 药物疗法 分子靶向治疗 Breast neoplasms Surgical procedures Radiotherapy Drag therapy Molecular tagertedtherapy
  • 相关文献

参考文献1

二级参考文献23

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin, 2011,61 (2):69-90. 被引量:1
  • 2Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2012,62(1): 10-29. 被引量:1
  • 3Bauer KR, Brown M, Cress RD, et al. Descriptive analysis of estrogen receptor (er)-negative, progesterone receptor (pr)-negative, and her2-negative invasive breast cancer, the so-called triple-negative phenotype: A popula-tion-based study from the California cancer registry. Cancer, 2007,109(9): 1721 -1728. 被引量:1
  • 4Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med, 2010,363(20): 1938-1948. 被引量:1
  • 5Shimizu C, Ando M, Kouno T, et al. Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer. Jpn J Clin Oncol, 2007,37(l):l-8. 被引量:1
  • 6Kaufmann M, von Minckwitz G, Smith R, et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: Review and recommendations. J Clin Oncol, 2003,21(13):2600 - 2608. 被引量:1
  • 7Keam B, Im S-A, Kim H-J, et al. Prognostic impact of clinicopathologic parameters in stage ii/iii breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: Paradoxical features of the triple negative breast cancer. BMC Cancer, 2007,7(1 ):203. 被引量:1
  • 8Wu J, Li S, Jia W, et al. Response and prognosis of tax-anes and anthracyclines neoadjuvant chemotherapy in patients with triple-negative breast cancer. J Cane Res Clin Oncol, 2011,137(10): 1505-1510. 被引量:1
  • 9Carey L, Dees E, Sawyer L, et al. The triple negative paradox: Primary tumor chemosensitivity of breast cancersubtypes. Clin Cancer Res, 2007,13(8):2329 - 2334. 被引量:1
  • 10Masuda H, Masuda N, Kodama Y, et al. Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients. Cancer Chemoth Pharm, 2011,67(4):911-917. 被引量:1

共引文献3

同被引文献81

  • 1章俊.siRNA干扰GADD45联合顺铂对人卵巢癌细胞增殖及凋亡的影响[J].中国老年学杂志,2014,34(6):1595-1597. 被引量:1
  • 2闫成.三阴性乳腺癌的临床研究进展[J].医学信息(下旬刊),2013,26(10):694. 被引量:2
  • 3张宇,李积德.三阴性乳腺癌的分子病理学特征及其治疗进展[J].中国保健营养(中旬刊),2012(4):640-641. 被引量:1
  • 4OnitiloAA, EngelJM, GreenleeRT, et al. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival[J]. Clin Med Res, 2009, 7(1-2):4-13. 被引量:1
  • 5GoldhirschA, WoodWC, CoatesAS, et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8): 1736-1747. 被引量:1
  • 6ChenXS, MaCD, WuJY, et al. Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer[J]. Tumori, 2010, 96(1):103-110. 被引量:1
  • 7ShuXO, ZhengY, CaiH, et al. Soy food intake and breast cancer survival[J]. JAMA, 2009, 302(22): 2437-2443. 被引量:1
  • 8SuY, ZhengY, ZhengW, et al. Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study[J]. BMC Cancer, 2011, 11:292. 被引量:1
  • 9CareyLA, PerouCM, LivasyCA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study[J]. JAMA, 2006, 295(21): 2492-2502. 被引量:1
  • 10O'BrienKM, ColeSR, TseCK, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study[J]. Clin Cancer Res, 2010, 16(24): 6100-6110. 被引量:1

引证文献7

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部